Ensuring balance in national policies on controlled substances : guidance for availability and accessibility of controlled medicines.
Material type: TextPublication details: Geneva : World Health Organization, 2011. Description: v, 78 p. : ill. ; 30 cmISBN: 9789241564175Subject(s): Drug control | Narcotics | Drugs | Medical policy | Drug and Narcotic Control | Narcotics | Prescription Drugs | Health PolicyNLM classification: QV 33.1 E 2011Summary: This book provides guidance on policies and legislation with regards to availability, accessibility, affordability and control of medicines made from substances regulated under the international drug control conventions, herein referred to as "controlled medicines". Their scope encompasses "all controlled medicines", but with a specific focus on essential medicines. Controlled medicines play an important role in several areas of medicine, including pain treatment, treatment of opioid dependence, emergency obstetrics, psychiatry and neurology. The availability, accessibility and affordability of controlled medicines are important issues for all countries, but problematic for most of them. This book elaborates on the background and then provides 21 guidelines on various topics: content of drug control legislation and policy; authorities and their role in the system; policy planning for availability and accessibility; healthcare professionals; estimates and statistics; procurement; and nationally listed drugs. Each guideline has an elucidation and a description of the legal context. The Country Assessment Checklist enables the user to determine which guidelines still need work. A CD-ROM provides additional information. Also endorsed by the International Narcotics Control Board.Item type | Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
WHO Publications | FNPH LIBRARY | QV 33.1 E 2011 (Browse shelf(Opens below)) | Available | 02859 |
Browsing FNPH LIBRARY shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | ||||||
QV 33 M 2011 Marketing authorization of pharmaceutical products with special reference to multisource (generic) products : | QV 33 Q 2004 Quality assurance of pharmaceuticals : | QV 33 Q 2007 Quality assurance of pharmaceuticals : | QV 33.1 E 2011 Ensuring balance in national policies on controlled substances : | QV 34 GH 2011 Fundamentals of experimental pharmacology. | QV 350 A 2011 Antimicrobial resistance : | QV 350 A 2011 Antimicrobial resistance : |
This book provides guidance on policies and legislation with regards to availability, accessibility, affordability and control of medicines made from substances regulated under the international drug control conventions, herein referred to as "controlled medicines". Their scope encompasses "all controlled medicines", but with a specific focus on essential medicines. Controlled medicines play an important role in several areas of medicine, including pain treatment, treatment of opioid dependence, emergency obstetrics, psychiatry and neurology. The availability, accessibility and affordability of controlled medicines are important issues for all countries, but problematic for most of them.
This book elaborates on the background and then provides 21 guidelines on various topics: content of drug control legislation and policy; authorities and their role in the system; policy planning for availability and accessibility; healthcare professionals; estimates and statistics; procurement; and nationally listed drugs. Each guideline has an elucidation and a description of the legal context. The Country Assessment Checklist enables the user to determine which guidelines still need work. A CD-ROM provides additional information.
Also endorsed by the International Narcotics Control Board.
There are no comments on this title.